SecBot SecBot
COURT-RULING ·Filed Jul 13, 2026

SYK

STRYKER CORP
BULLISH
Impact 6/10
Horizonweeks Processed4mo ago CourtCourt Ruling · govinfo.gov
Court ruling (district)
Actionable Insight ▲ Bullish

Stryker has now twice defeated Treace's antitrust claims at the pleading stage, significantly reducing the risk of a disruptive bundling challenge. However, patent infringement claims remain pending, and Treace may seek leave to amend again. Monitor for any third amended complaint or summary judgment motions on the patent counts.

DirectionBullish
Confidencehigh
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$311.07
T+0 close · Jul 14, 2026 · via day close
Latest settled
−11.47%
T+60 · $275.40
Vs SPY
−14.84%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 14 $311.07entry
  2. T+1 · 4mo ago +1.73%α +1.33% · $316.44
  3. T+5 · 4mo ago +1.13%α +1.60% · $314.58
  4. T+20 · 3mo ago +11.92%α +9.43% · $348.15
  5. T+60 · 6w ago −11.47%α −14.84% · $275.40
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Stryker won dismissal of Treace Medical's antitrust (Sherman Act, Clayton Act, state antitrust) and tortious interference claims without prejudice, marking the second time the court has rejected these counts at the pleading stage. The ruling removes the immediate threat of treble damages and injunctive relief from Stryker's bundling practices, though patent infringement claims remain pending.

Court Ruling Details

Ruling Date
Jul 13, 2026
Court
United States District Court for the District of New Jersey
Court Level
District
Judge
Jamel K. Semper
Case Type
antitrust
Ruling Type
motion to dismiss
Outcome
WIN: ruling favors this company
Precedent Risk
LOW

Key Facts

  • Court granted Stryker's motion to dismiss Counts XIII–XVI (antitrust and tortious interference) without prejudice.
  • Antitrust claims dismissed for failure to plead antitrust injury, allegations were conclusory and only showed harm to Treace, not to competition in the TMT bunion systems market.
  • Tortious interference claim dismissed because it was based on the same alleged anticompetitive conduct as the antitrust counts.
  • This is the second dismissal of these claims; the original complaint was dismissed in October 2025.
  • Patent infringement claims (Counts I–XII) remain active and were not addressed in this ruling.

Financial Impact

Dismissal of antitrust and tortious interference claims removes potential treble damages and injunctive relief exposure; patent claims remain pending with unknown damages exposure.

litigation riskantitrust exposure

Risk Factors

  • Treace may file a second amended complaint with more specific antitrust allegations, potentially reviving the dismissed counts.
  • Patent infringement claims (Counts I–XII) remain pending and could result in damages or injunctive relief if Stryker is found to infringe.

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
77% bullish (35 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-889e1f0a26-SYK

Track record

29 reports on SYK

Performance horizon

4 of 8 bullish or bearish reports moved the stock their way by T+20. Best: +23.40% at T+20 after the Oct 7, 2026 report. 6 of 10 went positive at some point.

Filters
  1. Nov 12, 20266d ago Court Ruling Neutral 3/10 Entry $309.64 Now $310.72 +0.35% settles Dec 14
  2. Nov 9, 20268d ago 8-K Neutral 2/10 Entry $324.29 Now $310.72 −4.18% settles Dec 9
  3. Nov 5, 202612d ago 144 Neutral 3/10 Entry $325.87 Now $310.72 −4.65% settles Dec 7
  4. Nov 4, 202613d ago S-3ASR Neutral 3/10 Entry $335.08 Now $310.72 −7.27% settles Dec 4
  5. Nov 3, 202614d ago Institutional Cluster Mixed 3/10 Entry $310.55 Now $310.72 +0.05% settles Dec 2
  6. Oct 29, 202619d ago 8-K Bearish 6/10 No price data
  7. Oct 29, 202619d ago Press Release Bearish 6/10 Entry $291.86 Now $310.72 −6.46% settles Nov 30
  8. Oct 26, 202622d ago Press Release Neutral 4/10 Entry $306.13 Now $310.72 +1.50% settles Nov 23
  9. Oct 20, 202629d ago PTAB Trial Bearish 5/10 Entry $297.60 Now $310.72 −4.41% settles Nov 18
  10. Oct 7, 20265w ago ANALYST-UPGRADE Bullish 4/10 Entry $275.25 to $339.65 Now $310.72 +12.89% ▲ +23.40% +24.74% vs SPY
Showing 10 of 29

US Market Status

Market Closed · Opens Thu (12h 1m)

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · govinfo.gov Report published Jul 14, 2026